chr16-89531949-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM5
The NM_003119.4(SPG7):c.1033G>A(p.Ala345Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000192 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A345P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003119.4 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 7Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003119.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPG7 | NM_003119.4 | MANE Select | c.1033G>A | p.Ala345Thr | missense | Exon 8 of 17 | NP_003110.1 | ||
| SPG7 | NM_001363850.1 | c.1033G>A | p.Ala345Thr | missense | Exon 8 of 18 | NP_001350779.1 | |||
| SPG7 | NM_199367.3 | c.1033G>A | p.Ala345Thr | missense | Exon 8 of 10 | NP_955399.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPG7 | ENST00000645818.2 | MANE Select | c.1033G>A | p.Ala345Thr | missense | Exon 8 of 17 | ENSP00000495795.2 | ||
| SPG7 | ENST00000268704.7 | TSL:1 | c.1012G>A | p.Ala338Thr | missense | Exon 8 of 17 | ENSP00000268704.3 | ||
| SPG7 | ENST00000341316.6 | TSL:1 | c.1033G>A | p.Ala345Thr | missense | Exon 8 of 10 | ENSP00000341157.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152236Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000359 AC: 9AN: 250854 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461748Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727202 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74488 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1033G>A (p.A345T) alteration is located in exon 8 (coding exon 8) of the SPG7 gene. This alteration results from a G to A substitution at nucleotide position 1033, causing the alanine (A) at amino acid position 345 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Hereditary spastic paraplegia 7 Uncertain:1
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SPG7 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1407118). This variant has not been reported in the literature in individuals affected with SPG7-related conditions. This variant is present in population databases (rs368373840, gnomAD 0.02%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 345 of the SPG7 protein (p.Ala345Thr).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at